Norwegian Finans Holding ASA
9.3.2021 08:02:04 CET | Globenewswire | Press release
On 4 March 2021, Nordax Bank AB (publ) ("Nordax") announced its intention to launch a voluntary offer for the shares in Norwegian Finans Holding ASA ("NFH" or "the Company"), subject to completion of satisfactory due diligence. The proposed offer price is NOK 95 per NFH share in cash, representing a 16.5% premium to the undisturbed closing price of NFH on 3 March 2021. After careful assessment, and also taking into consideration views expressed by shareholders, the Board of Directors of NFH has today responded to Nordax.
Given the Company’s best in class profitability, exceptionally strong capitalisation and standalone growth prospects, the Board of Directors believes that the indicated offer price significantly undervalues the Company and its prospects. Further, the Company notes that the minimum acceptance level of 50.1% of the shares of the company is undesirable both from a regulatory and governance perspective.
Taking all relevant considerations into account, the proposal by Nordax is not viewed by the Board of Directors to be in the best interest of the shareholders of the Company, and does therefore not form a basis for commencement of a process. The Board of Directors will evaluate any further proposals made by Nordax or any proposal made by any other party in the best interest of shareholders.
Arctic Securities AS and J.P. Morgan are acting as financial advisors and Advokatfirmaet Thommessen and Advokatfirmaet Simonsen Vogt Wiig are acting as legal advisors to NFH.
For any questions please call:
Klaus-Anders Nysteen, Chairman of the Board of Directors, phone: +47 99 26 56 91 / + 46 72-566 54 15
Tine Wollebekk, CEO, phone: +47 40 80 55 57
Klara-Lise Aasen, CFO, phone: +47 47 63 55 83
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd18.9.2026 22:32:00 CEST | Press release
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
Teva Pharmaceutical Industries Ltd18.9.2026 22:31:00 CEST | Press release
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs
Teva Pharmaceutical Industries Ltd18.9.2026 22:30:00 CEST | Press release
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
Leading Edge Materials Corp.18.9.2026 20:30:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2026 AND ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT
Orion Oyj18.9.2026 18:00:00 CEST | Press release
Orion Corporation: Acquisition of own shares during week 38, 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
